ING Groep NV Takes $4.65 Million Position in Bath & Body Works, Inc. (NYSE:BBWI) (2025)

ING Groep NV acquired a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 120,000 shares of the company's stock, valued at approximately $4,652,000. ING Groep NV owned about 0.06% of Bath & Body Works as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. FMR LLC grew its stake in Bath & Body Works by 17,496.5% in the 3rd quarter. FMR LLC now owns 2,516,127 shares of the company's stock valued at $80,315,000 after buying an additional 2,501,828 shares during the last quarter. KBC Group NV boosted its holdings in shares of Bath & Body Works by 9,023.5% during the third quarter. KBC Group NV now owns 1,701,813 shares of the company's stock worth $54,322,000 after acquiring an additional 1,683,160 shares during the period. Erste Asset Management GmbH bought a new stake in shares of Bath & Body Works during the third quarter worth approximately $50,483,000. Forest Avenue Capital Management LP grew its position in shares of Bath & Body Works by 19.1% in the third quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company's stock valued at $46,851,000 after purchasing an additional 235,173 shares during the last quarter. Finally, Verition Fund Management LLC increased its stake in shares of Bath & Body Works by 111.8% during the third quarter. Verition Fund Management LLC now owns 1,345,777 shares of the company's stock worth $42,957,000 after purchasing an additional 710,333 shares during the period. 95.14% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

BBWI has been the subject of several recent research reports. Raymond James restated an "outperform" rating and issued a $46.00 price target (up from $42.00) on shares of Bath & Body Works in a research note on Tuesday. Deutsche Bank Aktiengesellschaft upped their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a "buy" rating in a research note on Tuesday, November 26th. Wells Fargo & Company raised shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and raised their price target for the stock from $42.00 to $48.00 in a research report on Friday, January 10th. Piper Sandler boosted their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a "neutral" rating in a report on Monday, January 6th. Finally, Telsey Advisory Group reaffirmed an "outperform" rating and set a $43.00 target price on shares of Bath & Body Works in a report on Thursday, February 20th. Six analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $44.44.

Check Out Our Latest Stock Report on BBWI

Bath & Body Works Stock Performance

Shares of traded up $0.17 during trading on Tuesday, reaching $40.04. 1,485,697 shares of the company's stock were exchanged, compared to its average volume of 3,294,779. Bath & Body Works, Inc. has a 1-year low of $26.20 and a 1-year high of $52.99. The company has a market cap of $8.67 billion, a P/E ratio of 9.77, a PEG ratio of 0.92 and a beta of 1.83. The firm's 50-day moving average price is $37.73 and its 200 day moving average price is $33.96.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.46 by $0.03. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business's quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.48 earnings per share. As a group, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.00%. Bath & Body Works's payout ratio is presently 19.51%.

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

See Also

• Why Invest in High-Yield Dividend Stocks?
• NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
• What to Know About Investing in Penny Stocks
• Palantir Stock Nears Bear Market Territory - Why and What’s Next?
• There Are Different Types of Stock To Invest In
• Home Depot Turns a Corner: New Highs Likely This Year

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here